Tracking Response to Antidepressants in Advance of Investigational Trials, Relapse Study

NCT04933630 · clinicaltrials.gov ↗

COMPLETED

Status

27

Enrollment

NETWORK

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)

Sponsor

Adams Clinical